BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27591391)

  • 1. Mammaglobin and DOG-1 expression in polymorphous low-grade adenocarcinoma: an appraisal of its origin and morphology.
    Montalli VA; Passador-Santos F; Martinez EF; Furuse C; Aguiar MC; Soares FA; Soares AB; Brown AL; de Araújo NS; de Araújo VC
    J Oral Pathol Med; 2017 Mar; 46(3):182-187. PubMed ID: 27591391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
    J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese.
    Zhong Y; Liu L; Qi B; Song X; Shen L; Li H
    J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
    Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
    Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
    Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
    Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
    Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
    Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
    Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
    Fatima S; Ahmed A; Suleman S; Din NU
    Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
    Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
    Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Outcome in the Phenotypic Spectrum of Polymorphous Low-grade Adenocarcinoma (PLGA) and Cribriform Adenocarcinoma of Salivary Gland (CASG): A Retrospective Study of 69 Patients.
    Xu B; Aneja A; Ghossein R; Katabi N
    Am J Surg Pathol; 2016 Nov; 40(11):1526-1537. PubMed ID: 27454943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy.
    Araújo V; Sousa S; Jaeger M; Jaeger R; Loyola A; Crivelini M; Araújo N
    Oral Oncol; 1999 Mar; 35(2):164-72. PubMed ID: 10435151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma.
    Said-Al-Naief N; Carlos R; Vance GH; Miller C; Edwards PC
    Int J Surg Pathol; 2017 Apr; 25(2):127-140. PubMed ID: 27670353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphous low-grade adenocarcinoma of the salivary glands: clinicopathological and immunohistochemical study of a case.
    Tralongo V; Becchina G; Genovese F; Nagar C; Ottoveggio G; Pinto G
    Anticancer Res; 2002; 22(2B):1347-52. PubMed ID: 12168949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological observation of 10 cases of salivary secretory carcinoma].
    Liu YY; Tang XF; Wang FG; Wang YM; Liu N; Hu YH; Zhao CH; Yuan XH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Nov; 57(11):1128-1133. PubMed ID: 36379891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.